Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The RNA, U6 small nuclear 450, pseudogene (RNU6-450P) is a genomic pseudogene copy of the U6 small nuclear RNA gene family[1][7]. Pseudogenes are DNA sequences resembling functional genes but are typically non-functional due to accumulated mutations or lack of regulatory elements needed for expression[7]. U6 snRNA is a highly conserved component of the spliceosome involved in pre-mRNA splicing in eukaryotic nuclei[5]. RNU6-450P, as a pseudogene, does not code for a functional small nuclear RNA and is not involved in splicing or any known biological process[1][7]. Pseudogenes like RNU6-450P can arise from retrotransposition mediated by LINE-1 elements or gene duplication events, resulting in processed copies scattered throughout the genome[7]. While there is emerging interest in potential regulatory roles of some pseudogene transcripts (as competing endogenous RNAs or antisense RNAs), there is no evidence that RNU6-450P is functional or implicated in pathology or therapeutic targeting[1][7][6]. Notes: - RNU6-450P is not a therapeutic target and has no known biological or clinical function. - Its main use is in genomic studies as a marker of retrotransposition activity, not as a target molecule[7]. - There are no drugs, mechanisms, or biomarkers associated with this pseudogene. If more details on canonical small nuclear RNA U6 functions are needed, see U6 snRNA (not pseudogene) for spliceosome-related activities[5].
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 450, pseudogene (RNU6-450P).